May-01-24 05:00PM
|
|
Apr-23-24 08:30AM
|
|
Apr-09-24 07:35AM
|
|
Apr-08-24 09:55AM
|
|
Apr-04-24 11:33AM
|
|
12:00PM |
Loading… |
Apr-01-24 12:00PM
|
|
Mar-06-24 09:55AM
|
|
Mar-05-24 04:30PM
|
|
08:30AM
|
|
Mar-01-24 12:07AM
|
|
Feb-29-24 04:37PM
|
|
Feb-28-24 12:00PM
|
|
09:58AM
|
|
Feb-27-24 11:13PM
|
(Thomson Reuters StreetEvents) +18.28% |
06:34AM
|
|
06:00AM |
Loading… |
06:00AM
|
|
Feb-22-24 08:00AM
|
|
Feb-20-24 05:00PM
|
|
Jan-31-24 05:00PM
|
|
Jan-30-24 04:06AM
|
|
Jan-21-24 07:01AM
|
|
Dec-21-23 03:32PM
|
(Investor's Business Daily) |
Dec-11-23 08:00AM
|
|
Dec-01-23 11:04PM
|
|
Nov-12-23 12:15PM
|
|
Nov-09-23 04:05PM
|
|
Nov-01-23 06:35PM
|
|
Sep-06-23 08:00AM
|
|
Aug-30-23 04:30PM
|
|
Aug-28-23 10:22AM
|
|
09:00AM |
Loading… |
Aug-24-23 09:00AM
|
|
Aug-10-23 04:05PM
|
|
Aug-03-23 02:14PM
|
|
Aug-01-23 10:30PM
|
|
Jul-31-23 04:29PM
|
|
Jul-25-23 07:00AM
|
|
Jul-20-23 02:04PM
|
|
Jul-19-23 08:34PM
|
|
10:13AM
|
|
Jun-12-23 08:30AM
|
|
Jun-05-23 08:30AM
|
|
May-09-23 04:05PM
|
|
May-08-23 08:30AM
|
|
May-05-23 08:22AM
|
|
May-03-23 04:30PM
|
|
Apr-24-23 08:30AM
|
|
Apr-18-23 06:04AM
|
|
Apr-06-23 03:52PM
|
|
Mar-17-23 06:28AM
|
|
Mar-13-23 04:05PM
|
|
Mar-09-23 10:00AM
|
|
Mar-02-23 04:30PM
|
|
Feb-24-23 11:44AM
|
|
Jan-24-23 04:33AM
|
|
Dec-16-22 07:00AM
|
|
Dec-15-22 12:45PM
|
|
08:30AM
|
|
Dec-08-22 06:55AM
|
|
Nov-11-22 06:03AM
|
|
Nov-09-22 08:45AM
|
|
07:00AM
|
|
Oct-25-22 08:30AM
|
|
Oct-17-22 09:26AM
|
|
Oct-11-22 08:30AM
|
|
Oct-06-22 08:30AM
|
|
Sep-29-22 08:30AM
|
|
Sep-27-22 12:00PM
|
|
Sep-17-22 10:23AM
|
|
Sep-07-22 07:00AM
|
|
Aug-11-22 05:25PM
|
|
04:05PM
|
|
Aug-05-22 08:30AM
|
|
Jul-25-22 08:00AM
|
|
Jun-29-22 06:51AM
|
|
May-27-22 09:00AM
|
|
May-14-22 08:19AM
|
|
May-11-22 06:30AM
|
|
May-10-22 06:55PM
|
|
04:05PM
|
|
May-09-22 01:49PM
|
|
May-06-22 09:00AM
|
|
May-05-22 08:30AM
|
|
May-03-22 03:00PM
|
|
06:58AM
|
|
May-02-22 07:01AM
|
|
07:00AM
|
|
Apr-29-22 09:23PM
|
|
Apr-26-22 08:30AM
|
|
Apr-21-22 03:05AM
|
|
Mar-14-22 04:05PM
|
|
Mar-09-22 05:00PM
|
|
Feb-03-22 09:00AM
|
|
Feb-02-22 04:30PM
|
|
07:00AM
|
|
Jan-04-22 09:00AM
|
|
Nov-23-21 04:30PM
|
|
Nov-10-21 04:30PM
|
|
Nov-09-21 04:05PM
|
|
Nov-05-21 12:04PM
|
|
Nov-04-21 11:28AM
|
|
|
|
|
Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of therapeutic candidates. Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis. The company was founded by Bobak Azamian and D. Michael Ackermann in 2017 and is headquartered in Irvine, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Azamian Bobak R. | President/CEO and Board Chair | Mar 18 '24 | Sale | 30.60 | 10,415 | 318,699 | 26,456 | Mar 19 07:05 PM | Neervannan Seshadri | Chief Operating Officer | Mar 18 '24 | Sale | 30.60 | 4,879 | 149,297 | 64,767 | Mar 19 07:03 PM | Mottiwala Aziz | Chief Commercial Officer | Mar 18 '24 | Sale | 30.60 | 4,766 | 145,840 | 54,075 | Mar 19 07:08 PM | Wahl Bryan | General Counsel | Mar 18 '24 | Sale | 30.60 | 4,436 | 135,742 | 40,951 | Mar 19 07:05 PM | Whitfield Dianne C. | Chief Human Resources Officer | Mar 18 '24 | Sale | 30.60 | 4,314 | 132,008 | 34,181 | Mar 19 07:04 PM | Azamian Bobak R. | President/CEO and Board Chair | Dec 27 '23 | Sale | 20.22 | 8,000 | 161,760 | 830,106 | Dec 29 05:08 PM | Azamian Bobak R. | President/CEO and Board Chair | Dec 20 '23 | Sale | 20.27 | 40,000 | 810,623 | 838,106 | Dec 22 05:30 PM | Trevejo Jose M. | CHIEF MEDICAL OFFICER | Dec 20 '23 | Sale | 20.00 | 2,252 | 45,040 | 2,251 | Dec 22 05:32 PM | Goldberg Andrew D. | Director | Dec 15 '23 | Buy | 18.96 | 1,000 | 18,960 | 3,000 | Dec 19 06:30 PM | Wahl Bryan | General Counsel | Nov 30 '23 | Sale | 16.31 | 8,356 | 136,286 | 31,966 | Dec 01 04:55 PM | Whitfield Dianne C. | Chief Human Resources Officer | Nov 30 '23 | Sale | 16.31 | 8,355 | 136,270 | 26,784 | Dec 01 04:58 PM | Whitfield Dianne C. | Chief Human Resources Officer | Nov 29 '23 | Option Exercise | 0.00 | 23,920 | 0 | 35,139 | Dec 01 04:58 PM | Wahl Bryan | General Counsel | Nov 29 '23 | Option Exercise | 0.00 | 23,920 | 0 | 40,322 | Dec 01 04:55 PM | Azamian Bobak R. | President/CEO and Board Chair | Nov 15 '23 | Sale | 18.37 | 8,000 | 146,933 | 878,106 | Nov 17 04:50 PM | Azamian Bobak R. | President/CEO and Board Chair | Oct 18 '23 | Sale | 13.24 | 8,000 | 105,920 | 886,106 | Oct 20 04:41 PM | Trevejo Jose M. | CHIEF MEDICAL OFFICER | Oct 05 '23 | Sale | 18.00 | 1,604 | 28,872 | 4,503 | Oct 06 05:21 PM | Azamian Bobak R. | President/CEO and Board Chair | Sep 20 '23 | Sale | 17.21 | 8,000 | 137,680 | 894,106 | Sep 22 05:30 PM | Azamian Bobak R. | President/CEO and Board Chair | Aug 23 '23 | Sale | 17.23 | 8,000 | 137,840 | 902,106 | Aug 25 05:12 PM | Lin Elizabeth Yeu | Director | Aug 15 '23 | Buy | 16.80 | 9,506 | 159,701 | 15,866 | Aug 17 06:02 PM | Azamian Bobak R. | President/CEO and Board Chair | Jul 19 '23 | Sale | 20.01 | 103,900 | 2,078,984 | 910,106 | Jul 21 05:42 PM | Mottiwala Aziz | Chief Commercial Officer | Jul 19 '23 | Sale | 20.05 | 2,400 | 48,120 | 45,806 | Jul 21 05:46 PM | Azamian Bobak R. | President/CEO and Board Chair | Jul 12 '23 | Sale | 17.35 | 9,000 | 156,150 | 1,014,006 | Jul 14 04:40 PM | Azamian Bobak R. | President/CEO and Board Chair | Jun 21 '23 | Sale | 18.63 | 8,000 | 149,040 | 1,023,006 | Jun 23 04:29 PM | Azamian Bobak R. | President/CEO and Board Chair | Jun 14 '23 | Sale | 18.58 | 9,000 | 167,220 | 1,031,006 | Jun 16 04:48 PM | Azamian Bobak R. | President/CEO and Board Chair | Jun 08 '23 | Sale | 20.01 | 3,100 | 62,031 | 1,040,006 | Jun 12 05:40 PM | Mottiwala Aziz | Chief Commercial Officer | Jun 08 '23 | Sale | 20.00 | 100 | 2,000 | 48,086 | Jun 12 05:25 PM | Mottiwala Aziz | Chief Commercial Officer | Jun 07 '23 | Sale | 19.34 | 2,500 | 48,350 | 48,186 | Jun 08 07:16 PM | Mottiwala Aziz | Chief Commercial Officer | Jun 06 '23 | Sale | 18.61 | 2,143 | 39,881 | 50,686 | Jun 08 07:16 PM | Azamian Bobak R. | President/CEO and Board Chair | May 17 '23 | Sale | 15.90 | 8,000 | 127,200 | 1,043,106 | May 19 07:08 PM | Azamian Bobak R. | President/CEO and Board Chair | May 10 '23 | Sale | 16.80 | 9,000 | 151,200 | 1,051,106 | May 12 05:08 PM |
|